UnknownNot Applicable

Impact of Glenosphere Size on Range of Motion in Female Patients Undergoing Reverse Shoulder Arthroplasty

United States120 participantsStarted 2019-10-01

Plain-language summary

The purpose of this study is to perform a prospective randomized trial among female patients undergoing reverse shoulder arthroplasty (RSA) to determine if a larger glenosphere allows greater range of motion without an impact on complications.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female sex * Diagnosis of rotator cuff tear arthropathy or a massive irreparable rotator cuff tear for which the patient has elected to undergo reverse shoulder arthroplasty * No history of prior shoulder arthroplasty * Consent to study participation by signing the informed consent and the Protected Health Information (PHI) form (Attachment B and C) * Ability to speak, read and write English Exclusion Criteria: * Male sex * Any impairment that would prevent answering the surveys * No children or adolescents under the age of 18 years old * No prisoners, pregnant women, or mentally disabled persons * No Workers' Compensation cases

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Active range of motion

Timeframe: Change from baseline (pre-operative) to 2 years follow-up

Passive range of motion

Timeframe: Change from baseline (pre-operative) to 2 years follow-up

Trial details

NCT IDNCT04093804

SponsorFondren Orthopedic Group L.L.P.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-01

Contact for this trial

Mitzi S Laughlin, PhD

713-794-3408 Mitzi.Laughlin@fondren.com

View on ClinicalTrials.gov More Rotator Cuff Tear Arthropathy trials